Lupin Fact Sheet, Lupin Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Lupin Fact Sheet    (LUPL)


FREE Event: The Great Indian Wealth Project


Here is the latest financial fact sheet of Lupin. For more details, see the Lupin quarterly results and Lupin share price and chart. For a sector overview, read our pharmaceuticals sector report.

LUPIN Price History

Price Rs 1,200.8
Mkt Cap Rs m 543,516
Vol '000 256.1
P/E X 47.2
P/CF X 78.0
EPS (TTM) Rs 25.5
% ch % -1.8
No. of shares m 452.65
% ch week % 12.2
% ch 1-mth % 16.0
% ch 12-mth % 47.6
52 week H/L Rs 1,241.0/817.7
(As on May 11, 2021 03:36:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

LUPIN Financials

No. of Mths
Year Ending
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
LUPIN EQUITY SHARE DATA
High Rs2,1271,7501,465986882 
Low Rs1,2941,384727720505 
Sales per share (Unadj.) Rs316.4387.4349.6324.1339.4 
Earnings per share (Unadj.) Rs50.256.65.613.4-5.9 
Diluted earnings per shareRs49.956.55.613.4-6.0 
Cash flow per share (Unadj.) Rs61.076.829.632.115.5 
Dividends per share (Unadj.) Rs7.507.505.005.006.00 
Adj. dividends per shareRs7.477.484.995.006.00 
Dividend yield (eoy) %0.40.50.50.60.9 
Book value per share (Unadj.) Rs247.8298.9300.3303.7276.7 
Adj. book value per shareRs246.6298.2299.9303.6277.0 
Shares outstanding (eoy) m450.58451.58452.08452.49453.00 
Bonus/Rights/Conversions  -ESOPESOPESOPESOP 
Price / Sales ratio x5.44.03.12.62.0 
Avg P/E ratio x34.127.7197.263.6-116.6 
P/CF ratio (eoy) x28.020.437.126.644.8 
Price / Book Value ratio x6.95.23.62.82.5 
Dividend payout %14.913.290.037.3-100.9 
Avg Mkt Cap Rs m770,740707,513495,502386,064314,201 
No. of employees `00016.416.817.017.718.3 
Total wages/salary Rs m21,41628,49528,64727,70229,868 
Avg. sales/employee Rs Th8,718.510,418.39,273.68,292.68,400.6 
Avg. wages/employee Rs Th1,309.81,697.01,681.01,566.51,632.0 
Avg. net profit/employee Rs Th1,382.61,523.0147.4343.0-147.2 
LUPIN INCOME DATA
Net Sales Rs m142,555174,943158,042146,646153,748 
Other income Rs m1,8521,0651,5043,3304,838 
Total revenues Rs m144,407176,008159,545149,976158,585 
Gross profit Rs m36,85444,93131,47526,55224,849 
Depreciation Rs m4,8719,12210,8598,4619,702 
Interest Rs m5951,5252,0443,0253,630 
Profit before tax Rs m33,23935,34920,07618,39716,355 
Minority Interest Rs m-88-72-71-894 
Prior Period Items Rs m4983353839 
Extraordinary Inc (Exp) Rs m00-14,644-3,400-7,521 
Tax Rs m10,5939,7852,8858,87911,571 
Profit after tax Rs m22,60725,5752,5136,066-2,694 
Gross profit margin %25.925.719.918.116.2 
Effective tax rate %31.927.714.448.370.8 
Net profit margin %15.914.61.64.1-1.8 
LUPIN BALANCE SHEET DATA
Current assets Rs m98,874119,529122,095138,536154,132 
Current liabilities Rs m50,61261,20650,95661,29992,252 
Net working cap to sales %33.933.345.052.740.2 
Current ratio x2.02.02.42.31.7 
Inventory Days Days8476859582 
Debtors Days Days11690120128129 
Net fixed assets Rs m114,194131,660129,876127,51689,082 
Share capital Rs m901903904905906 
"Free" reserves Rs m110,733134,073134,866136,517124,461 
Net worth Rs m111,634134,976135,771137,422125,367 
Long term debt Rs m53,73956,47864,24566,41717,933 
Total assets Rs m226,249266,073263,054279,494249,839 
Interest coverage x56.924.210.87.15.5 
Debt to equity ratio x0.50.40.50.50.1 
Sales to assets ratio x0.60.70.60.50.6 
Return on assets %10.310.21.73.30.4 
Return on equity %20.318.91.94.4-2.1 
Return on capital %20.419.33.78.88.7 
Exports to sales %47.20000 
Imports to sales %7.20000 
Exports (fob) Rs m67,2440000 
Imports (cif) Rs m10,1990000 
Fx inflow Rs m71,40581,88553,14159,41451,450 
Fx outflow Rs m17,80721,50619,33522,28219,470 
Net fx Rs m53,59860,37833,80737,13231,980 
LUPIN CASH FLOW
From Operations Rs m -3,824 41,135 17,512 16,660 14,688 
From Investments Rs m -69,617 -25,274 4,699 -32,825 11,070 
From Financial Activity Rs m 58,364 4,332 -14,921 7,441 -8,906 
Net Cashflow Rs m -15,077 20,193 7,290 -8,724 16,853 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 46.6%
Foreign collaborators 0.2%
Indian inst/Mut Fund 11.3%
FIIs 31.9%
ADR/GDR 0.0%
Free float 10.1%
Shareholders 98,259
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 159, C.S.T. Road, Kalina, Santacruz (E), Mumbai - 400 098
E-MAIL rajvardhansatam@lupinpharma.com WEB www.lupinworld.com
TELEPHONE (022) 6640 2323 FAX (022) 2652 8806
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT In-house
AUDITOR Deloitte Haskins & Sells
CHM: D. B. Gupta COMP SEC: R. V. Satam YEAR OF INC: 1983 BSE CODE: 500257 FV (Rs): 2 DIV YIELD (%): 0.5

Read: LUPIN 2019-20 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   SANOFI INDIA  PANACEA BIOTECH  GSK PHARMA  SUVEN LIFE SCIENCES  NOVARTIS  

Compare LUPIN With:   SANOFI INDIA  PANACEA BIOTECH  GSK PHARMA  SUVEN LIFE SCIENCES  NOVARTIS  

Compare LUPIN With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  




Today's Market

Sensex, Nifty Snap 4-Day Winning Streak; JSW Steel and Hindalco Among Top Losers(Closing)

Indian share markets witnessed selling pressure throughout the day today and ended lower.

Views on news

LUPIN 2019-20 Annual Report Analysis (Annual Result Update)

Dec 7, 2020 | Updated on Dec 7, 2020

Here's an analysis of the annual report of LUPIN for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

LUPIN Announces Quarterly Results (2QFY21); Net Profit Up 271.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, LUPIN has posted a net profit of Rs 2 bn (up 271.3% YoY). Sales on the other hand came in at Rs 38 bn (down 12.0% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN Announces Quarterly Results (1QFY21); Net Profit Down 64.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, LUPIN has posted a net profit of Rs 1 bn (down 64.2% YoY). Sales on the other hand came in at Rs 35 bn (down 20.2% YoY). Read on for a complete analysis of LUPIN's quarterly results.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

Sell in May and Go Away? (Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TRACK LUPIN

MORE ON LUPIN

LUPIN - TEVA PHARMA COMPARISON

COMPARE LUPIN WITH

MARKET STATS